Tectonic Therapeutic | AVRO - Market Capitalization

Stock Price
28.54
Daily Change
0.10 0.35%
Monthly
-8.11%
Yearly
35.32%
Q2 Forecast
27.93

Tectonic Therapeutic reported $411.6M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Cspc Pharmaceutical CNY 87.29B 19.74B Dec/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Gilead Sciences USD 166.62B 14.34B Apr/2026
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
MacroGenics USD 102M 4M Dec/2025
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pfizer USD 141.57B 6.48B Dec/2025
Pharma Mar EUR 1.67B 317.89M Apr/2026
Qiagen NV USD 9.9B 207.4M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 101.43B 1.16B Apr/2026
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Sartorius EUR 7.48B 6.76B Apr/2026
Takeda JPY 7.64T 774.9B Dec/2025
Zealand Pharma A/S 33.35B 0 Apr/2026
Zz Pientze Pharmaceu CNY 86.94B 31.78B Apr/2026